Skip to main content
AAPS Open
Fig. 17 | AAPS Open

Fig. 17

From: Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infections

Fig. 17

Supernatant niclosamide (µM) vs. supernatant pH: Expanded view of plot in Fig. 10 with added data for the TBSS system at final pHs of 8.31 (pale yellow-green filled circle, 11.3 µM) and 9.21 (orange-red-filled circle, 30.7 µM) as probably niclosamide sodium. Inset: photographic image of equilibrated samples showing the pale yellow-green appearance of the Yomesan niclosamide in nominal pH 9.35 TB (left) and the orange-red appearance of the Yomesan-niclosamide in nominal 9.35 TBSS (right). Also (lower right), microscopic image of the morphology of the grown crystals

Back to article page